Related Experiment Videos

The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways

C B Martin1, G M Mahon, M B Klinger

  • 1Department of Pharmacology and Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina NC 27599-7295, USA.

Oncogene
|May 22, 2001
PubMed

Insights

Thrombin-stimulated G protein-coupled receptor PAR-1 acts as an oncogene, promoting NIH3T3 cell transformation and growth. PAR-1

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncogenesis

Background:

  • Oncogenes drive cellular transformation and tumor development.
  • G protein-coupled receptors (GPCRs) play diverse roles in cell signaling.
  • Protease-activated receptor 1 (PAR-1) is activated by thrombin.

Purpose of the Study:

  • To identify novel oncogenes involved in cell transformation.
  • To investigate the role of PAR-1 in NIH3T3 cell growth and transformation.
  • To elucidate the signaling pathways mediating PAR-1-induced transformation.

Main Methods:

  • cDNA expression library screening in NIH3T3 cells.
  • Analysis of anchorage- and serum-dependent growth.
  • Investigation of RhoA activation and downstream signaling.
  • G protein subunit involvement using pertussis toxin and RGS domain.

Main Results:

  • A 2.2 kb cDNA encoding wild-type PAR-1 was identified as a transforming oncogene.
  • PAR-1 overexpression induced focus formation and loss of growth control.
  • PAR-1 transformation involved RhoA activation, stress fiber formation, and transcription factor stimulation.
  • Galpha(i) and Galpha(12)/Galpha(13) subunits mediate PAR-1 signaling.

Conclusions:

  • PAR-1 functions as an oncogene promoting cell transformation.
  • PAR-1-mediated transformation involves RhoA activation and downstream signaling pathways.
  • PAR-1 signaling is mediated by Galpha(i) and Galpha(12)/Galpha(13) G protein subunits.

Related Concept Videos